News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News Anger, Physical Exertion May Up Risk of Acute MI for Some—but Not All L.A. McKeown October 12, 2016
News Daily News Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT Michael O'Riordan September 29, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Daily News Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas Todd Neale September 19, 2016
News Daily News Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins Todd Neale September 19, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds Yael L. Maxwell August 29, 2016
News Daily News Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9 Yael L. Maxwell August 29, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space Michael O'Riordan August 01, 2016
News Daily News Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly Michael O'Riordan July 21, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use Michael O'Riordan June 28, 2016